Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 240

1.

Tissue factor induced by epithelial-mesenchymal transition triggers a pro-coagulant state that drives metastasis of circulating tumor cells.

Bourcy M, Suarez-Carmona M, Lambert J, Francart ME, Schroeder H, Delierneux C, Skrypek N, Thompson EW, Jerusalem G, Berx G, Thiry M, Blacher S, Hollier BG, Noel A, Oury C, Polette M, Gilles C.

Cancer Res. 2016 May 24. pii: canres.2263.2015. [Epub ahead of print]

PMID:
27221703
2.

Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells.

Tachtsidis A, McInnes LM, Jacobsen N, Thompson EW, Saunders CM.

Clin Exp Metastasis. 2016 May 17. [Epub ahead of print] Review.

PMID:
27189371
3.

Janus kinases and Src family kinases in the regulation of EGF-induced vimentin expression in MDA-MB-468 breast cancer cells.

Stewart TA, Azimi I, Brooks AJ, Thompson EW, Roberts-Thomson SJ, Monteith GR.

Int J Biochem Cell Biol. 2016 May 7;76:64-74. doi: 10.1016/j.biocel.2016.05.007. [Epub ahead of print]

PMID:
27163529
4.

Exemplary multiplex bisulfite amplicon data used to demonstrate the utility of Methpat.

Wong NC, Pope BJ, Candiloro I, Korbie D, Trau M, Wong SQ, Mikeska T, van Denderen BJ, Thompson EW, Eggers S, Doyle SR, Dobrovic A.

Gigascience. 2015 Nov 26;4:55. doi: 10.1186/s13742-015-0098-x. eCollection 2015.

5.

Heterogeneity of miR-10b expression in circulating tumor cells.

Gasch C, Plummer PN, Jovanovic L, McInnes LM, Wescott D, Saunders CM, Schneeweiss A, Wallwiener M, Nelson C, Spring KJ, Riethdorf S, Thompson EW, Pantel K, Mellick AS.

Sci Rep. 2015 Nov 2;5:15980. doi: 10.1038/srep15980.

6.

An epithelial to mesenchymal transition programme does not usually drive the phenotype of invasive lobular carcinomas.

McCart Reed AE, Kutasovic JR, Vargas AC, Jayanthan J, Al-Murrani A, Reid LE, Chambers R, Da Silva L, Melville L, Evans E, Porter A, Papadimos D, Thompson EW, Lakhani SR, Simpson PT.

J Pathol. 2016 Mar;238(4):489-94. doi: 10.1002/path.4668. Epub 2016 Feb 1.

PMID:
26510554
7.

Proteoglycans: Potential Agents in Mammographic Density and the Associated Breast Cancer Risk.

Shawky MS, Ricciardelli C, Lord M, Whitelock J, Ferro V, Britt K, Thompson EW.

J Mammary Gland Biol Neoplasia. 2015 Dec;20(3-4):121-31.

PMID:
26501889
8.

Altered purinergic receptor-Ca²⁺ signaling associated with hypoxia-induced epithelial-mesenchymal transition in breast cancer cells.

Azimi I, Beilby H, Davis FM, Marcial DL, Kenny PA, Thompson EW, Roberts-Thomson SJ, Monteith GR.

Mol Oncol. 2016 Jan;10(1):166-78. doi: 10.1016/j.molonc.2015.09.006. Epub 2015 Sep 25.

PMID:
26433470
9.

Editorial: Cellular and Phenotypic Plasticity in Cancer.

Ferrao PT, Behren A, Anderson RL, Thompson EW.

Front Oncol. 2015 Aug 4;5:171. doi: 10.3389/fonc.2015.00171. eCollection 2015. No abstract available.

10.

An optimised direct lysis method for gene expression studies on low cell numbers.

Le AV, Huang D, Blick T, Thompson EW, Dobrovic A.

Sci Rep. 2015 Aug 5;5:12859. doi: 10.1038/srep12859.

11.

Increased COX-2 expression in epithelial and stromal cells of high mammographic density tissues and in a xenograft model of mammographic density.

Chew GL, Huo CW, Huang D, Hill P, Cawson J, Frazer H, Hopper JL, Haviv I, Henderson MA, Britt K, Thompson EW.

Breast Cancer Res Treat. 2015 Aug;153(1):89-99. doi: 10.1007/s10549-015-3520-2. Epub 2015 Jul 31.

PMID:
26227474
12.

New Insights on COX-2 in Chronic Inflammation Driving Breast Cancer Growth and Metastasis.

Hugo HJ, Saunders C, Ramsay RG, Thompson EW.

J Mammary Gland Biol Neoplasia. 2015 Dec;20(3-4):109-19. doi: 10.1007/s10911-015-9333-4. Epub 2015 Jul 21.

PMID:
26193871
13.

High mammographic density is associated with an increase in stromal collagen and immune cells within the mammary epithelium.

Huo CW, Chew G, Hill P, Huang D, Ingman W, Hodson L, Brown KA, Magenau A, Allam AH, McGhee E, Timpson P, Henderson MA, Thompson EW, Britt K.

Breast Cancer Res. 2015 Jun 4;17:79. doi: 10.1186/s13058-015-0592-1.

14.

Stimulus-dependent differences in signalling regulate epithelial-mesenchymal plasticity and change the effects of drugs in breast cancer cell lines.

Cursons J, Leuchowius KJ, Waltham M, Tomaskovic-Crook E, Foroutan M, Bracken CP, Redfern A, Crampin EJ, Street I, Davis MJ, Thompson EW.

Cell Commun Signal. 2015 May 15;13:26. doi: 10.1186/s12964-015-0106-x.

15.

Differential effects of superoxide dismutase and superoxide dismutase/catalase mimetics on human breast cancer cells.

Shah MH, Liu GS, Thompson EW, Dusting GJ, Peshavariya HM.

Breast Cancer Res Treat. 2015 Apr;150(3):523-34. doi: 10.1007/s10549-015-3329-z. Epub 2015 Mar 21.

PMID:
25794772
16.

Clinical implications of circulating tumor cells of breast cancer patients: role of epithelial-mesenchymal plasticity.

McInnes LM, Jacobson N, Redfern A, Dowling A, Thompson EW, Saunders CM.

Front Oncol. 2015 Feb 26;5:42. doi: 10.3389/fonc.2015.00042. eCollection 2015. Review.

17.

A role for calcium in the regulation of ATP-binding cassette, sub-family C, member 3 (ABCC3) gene expression in a model of epidermal growth factor-mediated breast cancer epithelial-mesenchymal transition.

Stewart TA, Azimi I, Thompson EW, Roberts-Thomson SJ, Monteith GR.

Biochem Biophys Res Commun. 2015 Mar 13;458(3):509-14. doi: 10.1016/j.bbrc.2015.01.141. Epub 2015 Feb 7.

PMID:
25666946
18.

The ubiquitin ligase Siah is a novel regulator of Zeb1 in breast cancer.

Chen A, Wong CS, Liu MC, House CM, Sceneay J, Bowtell DD, Thompson EW, Möller A.

Oncotarget. 2015 Jan 20;6(2):862-73.

19.

Effects of Tamoxifen and oestrogen on histology and radiographic density in high and low mammographic density human breast tissues maintained in murine tissue engineering chambers.

Chew GL, Huo CW, Huang D, Blick T, Hill P, Cawson J, Frazer H, Southey MC, Hopper JL, Britt K, Henderson MA, Haviv I, Thompson EW.

Breast Cancer Res Treat. 2014 Nov;148(2):303-14. doi: 10.1007/s10549-014-3169-2. Epub 2014 Oct 21.

PMID:
25332094
20.

High threshold of β1 integrin inhibition required to block collagen I-induced membrane type-1 matrix metalloproteinase (MT1-MMP) activation of matrix metalloproteinase 2 (MMP-2).

Borrirukwanit K, Pavasant P, Blick T, Lafleur MA, Thompson EW.

Cancer Cell Int. 2014 Oct 3;14(1):99. doi: 10.1186/s12935-014-0099-3. eCollection 2014.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk